Tread carefully in vaccine CMO selection

Vaccine manufacturing poses unique challenges in process and product development. Use of a contract manufacturer can be both effective and economical, however, but pay attention to the RFP-creation and short-listing steps, two of the four involved in making a selection. Article

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.